Saskia de Man, Sergei Chavez Abiega, Tomas Veenendaal, Michelle Kop, Jarmil Hanrath, Daniel Okkes, Emma Spanjaard, Leo Price1, Gera Goverse

This research details the innovative approach of Crown Bioscience's high-content screening platform, designed to evaluate immunotherapies across a wide range of cancer models using patient-derived organoids (PDOs).
This groundbreaking technology enables more accurate predictions of therapeutic efficacy, leveraging advanced imaging and co-culture systems to provide insights into immune response across various cancer types. Explore the potential of this platform to accelerate immunotherapy research by enabling comprehensive and scalable in vitro testing.
Your privacy is important to us.
We'll never share your information.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy
2025-06-06
2024-10-22
landing_page
In Vitro: Amplify Organoids